Overview

ACTH for Fatigue in Multiple Sclerosis Patients

Status:
Completed
Trial end date:
2018-12-13
Target enrollment:
Participant gender:
Summary
This is a study of Acthar gel (ACTH) in patients with relapsing multiple sclerosis who are experiencing chronic fatigue.
Phase:
Phase 3
Details
Lead Sponsor:
Providence Health & Services
Collaborator:
Mallinckrodt
Treatments:
Adrenocorticotropic Hormone